Thomas H McLain's Net Worth

$973 Thousand

Estimate Recalculated Nov 8, 2024 09:32PM EST

Who is Thomas H McLain

Thomas H McLain does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include EASTMAN CHEMICAL CO, VERMILLION, INC., Renalytix plc, and NABI BIOPHARMACEUTICALS.

SEC CIK

Thomas H McLain's CIK is 0001206465

Past Insider Trading and Trends

2006 was Thomas H McLain's most active year for acquiring shares with 9 total transactions. Thomas H McLain's most active month to acquire stocks was the month of April. 2011 was Thomas H McLain's most active year for disposing of shares, totalling 10 transactions. Thomas H McLain's most active month to dispose stocks was the month of October. 2011 saw Thomas H McLain paying a total of $599,000.00 for 21,112 shares, this is the most they've acquired in one year. In 2011 Thomas H McLain cashed out on 40,000 shares for a total of $784,200.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EASTMAN CHEMICAL CO

Investor
Updated Dec 02, 2011
Form 4
-70.35%
-20.00K
$34.58
-$185.20K
Dec 02, 2011
8.53K
Sale
Nov 30
Form 4
7.64%
368.00
Oct 05, 2011
5.19K
Grant
Oct 03
Form 4
13.25%
493.00
May 09, 2011
4.27K
Grant
May 05
Form 4
5.57%
251.00
Apr 05, 2011
4.76K
Grant
Apr 01
Form 4
8.19%
338.00
Oct 05, 2010
4.46K
Grant
Oct 01
Form 4
27.25%
797.00
May 10, 2010
3.77K
Grant
May 06
Form 4
10.52%
387.00
Apr 05, 2010
4.07K
Grant
Apr 01
Form 4
15.68%
492.00
Oct 02, 2009
3.63K
Grant
Oct 01
Form 4
72.57%
1.23K
May 11, 2009
2.98K
Grant
May 07
Form 4
40.62%
888.00
Apr 03, 2009
3.07K
Grant
Apr 01
Form 4
24.36%
416.00
Oct 02, 2008
2.12K
Grant
Oct 01
Form 4
127.24%
2.07K
May 05, 2008
3.75K
Grant
May 01
Form 4
26.71%
355.00
Apr 02, 2008
1.68K
Grant
Apr 01
Form 4
34.53%
336.00
Oct 03, 2007
1.31K
Grant
Oct 01
Form 4
156.06%
991.00
$65.73
$65.14K
May 29, 2007
1.68K
Purchase
May 24
Form 4
370.54%
2.08K
May 07, 2007
2.69K
Grant
May 03
Form 4
59.11%
357.00
Apr 04, 2007
961.00
Grant
Apr 02
Form 4
31.06%
141.00
Oct 04, 2006
595.00
Grant
Oct 02
Form 4
443.52%
2.09K
May 08, 2006
2.61K
Grant
May 04
Form 4
49.66%
148.00
Apr 05, 2006
446.00
Grant
Apr 03
Form 4
125.38%
163.00
Oct 05, 2005
293.00
Grant
Oct 03
Form 4
540.16%
2.08K
May 09, 2005
2.52K
Grant
May 05
Form 4
128.00
Apr 05, 2005
128.00
Grant
Apr 01
Form 4
777.21%
2.11K
May 10, 2004
2.44K
Grant
May 06
Form 3
Feb 17, 2004
324.00
Showing 25 results

VERMILLION, INC.

President & CEO
Updated Mar 31, 2014
Form 4
35.00%
140.00K
Mar 31, 2014
540.00K
Grant
Mar 27
Form 4
400.00K
Dec 16, 2013
400.00K
Grant
Dec 12
Form 3
Mar 20, 2013
Showing 3 results

Renalytix plc

President
Updated Jul 11, 2023
Form 4
200.00K
Jul 11, 2023
200.00K
Grant
Jul 10
Form 4
394.49K
Jul 07, 2023
394.49K
Grant
Jul 06
Form 3
Jul 03, 2023
59.15K
Showing 3 results

NABI BIOPHARMACEUTICALS

Chairman, CEO & President
Updated Aug 17, 2006
Form 4
3.90%
4.76K
$2.73
$13.00K
Aug 17, 2006
190.53K
Acquisition
May 31
Form 4
92.90%
95.00K
May 16, 2006
260.77K
Grant
May 12
Form 4
328.82%
143.07K
Feb 28, 2006
250.10K
Grant
Feb 24
Form 4
63.27K
$3.48
$219.87K
Nov 21, 2005
112.29K
Acq/Dis
Nov 15
Form 4
2.58%
1.23K
$10.58
$13.00K
Sep 15, 2005
49.02K
Acquisition
May 31
Form 4
150.00K
Mar 16, 2005
150.00K
Grant
Mar 14
Form 4
2.27%
1.06K
$12.30
$13.00K
Dec 20, 2004
47.79K
Acquisition
Nov 30
Form 4
84.62%
110.00
$10.45
$1.15K
Aug 10, 2004
46.73K
Purchase
Aug 06
Form 4
3.12%
1.41K
$9.23
$13.00K
Jun 22, 2004
46.62K
Acquisition
May 31
Form 4
15.51K
May 18, 2004
15.51K
Grant
May 14
Form 4
102.72K
Mar 26, 2004
102.72K
Grant
Mar 24
Form 4
5.10%
2.19K
$5.94
$13.00K
Feb 06, 2004
45.21K
Acquisition
Nov 30
Form 4
5.38%
2.19K
$5.94
$13.00K
Nov 03, 2003
43.02K
Acquisition
May 31
Showing 13 results